Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Stabin

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Evolution and status of bone and marrow dose modelsM G Stabin, K F Eckerman, W E Bolch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1986
A new osmium-191/iridium-191m radionuclide generator system using activated carbonC Brihaye, T A Butler, F F Knapp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptorP D Mozley, J B Stubbs, H F Kung, et al.
Nuclear Medicine Communications|March 1, 1988
Dosimetry of leukocytes labeled with 99Tcm-albumin colloidC S Marcus, M G Stabin, E E Watson, et al.
Health Physics|October 13, 2010
Image quantification for radiation dose calculations--limitations and uncertaintiesJ M Pereira, M G Stabin, F R A Lima, et al.
European Journal of Nuclear Medicine|March 7, 1998
Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transportersJ Booij, E Busemann Sokole, M G Stabin, et al.
European Journal of Nuclear Medicine|February 5, 1999
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patientsM Cremonesi, M Ferrari, M Chinol, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinomaL C Washburn, Y C Lee, T T Sun, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|April 17, 2001
Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experienceM Cremonesi, M Ferrari, M Chinol, et al.
European Journal of Nuclear Medicine|March 7, 1998
Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imagingL J Rijks, E Busemann Sokole, M G Stabin, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Evolution and status of bone and marrow dose modelsM G Stabin, K F Eckerman, W E Bolch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1986
A new osmium-191/iridium-191m radionuclide generator system using activated carbonC Brihaye, T A Butler, F F Knapp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptorP D Mozley, J B Stubbs, H F Kung, et al.
Nuclear Medicine Communications|March 1, 1988
Dosimetry of leukocytes labeled with 99Tcm-albumin colloidC S Marcus, M G Stabin, E E Watson, et al.
Health Physics|October 13, 2010
Image quantification for radiation dose calculations--limitations and uncertaintiesJ M Pereira, M G Stabin, F R A Lima, et al.
European Journal of Nuclear Medicine|March 7, 1998
Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transportersJ Booij, E Busemann Sokole, M G Stabin, et al.
European Journal of Nuclear Medicine|February 5, 1999
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patientsM Cremonesi, M Ferrari, M Chinol, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinomaL C Washburn, Y C Lee, T T Sun, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|April 17, 2001
Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experienceM Cremonesi, M Ferrari, M Chinol, et al.
European Journal of Nuclear Medicine|March 7, 1998
Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imagingL J Rijks, E Busemann Sokole, M G Stabin, et al.
Pageof 8